Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
2
|
pubmed:dateCreated |
1996-12-16
|
pubmed:abstractText |
We have investigated an improved method for generating sizable numbers of mature dendritic cells from nonproliferating progenitors in human blood. The procedure uses 1% human plasma in the place of 10% fetal calf serum and involves two steps. The first step or 'priming' phase is a 6-7 day culture of T cell depleted mononuclear cells in medium supplemented with GM-CSF and IL-4. The second step or 'differentiation' phase requires the exposure to macrophage conditioned medium. This medium cannot be replaced by several known cytokines such as TNF-alpha, IL-1, IL-6, IL-12 and IL-15, and cannot be inhibited with neutralizing antibodies to IL-1, TNF-alpha, IL-6 or IL-12 alone, or in combination. Using this two-step approach, we obtain substantial yields. About 1-3 x 10(6) mature dendritic cells are generated from 40 ml of blood vs. < 0.1 x 10(6) from noncytokine treated blood. The dendritic cells derive from progenitors found primarily in a radioresistant population of CD14+ and adherent blood mononuclear cells and have all the features of mature cells. They include a stellate cell shape, nonadherence to plastic, and very strong T cell stimulatory activity. Strong APC function was evident for both the proliferation of allogeneic T cells in the MLR, and the generation by syngeneic T cells of class I restricted, CTL responses to influenza virus. A panel of dendritic cell restricted markers is also expressed, including CD83, p55, and perinuclear CD68. All of these dendritic cell properties are retained for at least 3 days when the cytokines are removed, suggesting that these populations are stable and terminally differentiated. We suggest that these cells will be effective in vivo as adjuvants for active immunotherapy.
|
pubmed:grant | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Sep
|
pubmed:issn |
0022-1759
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
27
|
pubmed:volume |
196
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
121-35
|
pubmed:dateRevised |
2007-11-14
|
pubmed:meshHeading |
pubmed-meshheading:8841451-Cell Culture Techniques,
pubmed-meshheading:8841451-Cell Differentiation,
pubmed-meshheading:8841451-Cell Division,
pubmed-meshheading:8841451-Culture Media, Conditioned,
pubmed-meshheading:8841451-Cytokines,
pubmed-meshheading:8841451-Dendritic Cells,
pubmed-meshheading:8841451-Granulocyte-Macrophage Colony-Stimulating Factor,
pubmed-meshheading:8841451-Hematopoietic Stem Cells,
pubmed-meshheading:8841451-Humans,
pubmed-meshheading:8841451-Immunophenotyping,
pubmed-meshheading:8841451-Influenza A virus,
pubmed-meshheading:8841451-Interleukin-4,
pubmed-meshheading:8841451-Leukocytes, Mononuclear,
pubmed-meshheading:8841451-Lymphocyte Activation,
pubmed-meshheading:8841451-T-Lymphocytes
|
pubmed:year |
1996
|
pubmed:articleTitle |
Improved methods for the generation of dendritic cells from nonproliferating progenitors in human blood.
|
pubmed:affiliation |
Rockefeller University, New York 10021, USA.
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, P.H.S.,
Research Support, Non-U.S. Gov't
|